newsfilter
← Latest News
PR Newswire·

BioLineRx to Report Second Quarter 2025 Results on August 14, 2025

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...